Rancho Biosciences Welcomes BenevolentAI as New Member to Its Single Cell Data Science Consortium
01. Februar 2023 09:00 ET
|
Rancho BioSciences, LLC
SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- On Feb. 26, 2022, Rancho Biosciences, a leading data sciences services company, launched its Single Cell Data Science (SCDS) pre-competitive consortium,...
Rancho Biosciences Launches the Single Cell Data Science Consortium With Four Charter Members
02. Mai 2022 08:00 ET
|
Rancho BioSciences, LLC
SAN DIEGO, May 02, 2022 (GLOBE NEWSWIRE) -- Rancho Biosciences, a leading company in the field of data curation and data services, is pleased to announce the launch of its Single Cell Data Science...
Fluidigm Announces Conference Call and Webcast of Third Quarter 2021 Financial Results
20. Oktober 2021 08:30 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm Announces Virtual Mass Cytometry Webinar Investor Event on May 24, 2021, at 1:00 p.m. Eastern Time
10. Mai 2021 13:30 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., May 10, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm to Participate at the Piper Sandler 32nd Annual Virtual Healthcare Conference
20. November 2020 21:54 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 20, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm to Present at Upcoming Health Care Investor Conference
10. November 2020 08:30 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm Announces Third Quarter 2020 Financial Results
05. November 2020 16:05 ET
|
Fluidigm Corporation
Third Quarter Total Revenue Increased 50 Percent to $39.9 Million Third Quarter Product and Service Revenue Increased 34 Percent to $35.3 Million Driven by COVID-19 Testing GAAP Net Loss in the...
Fluidigm to Participate at the 2020 Cantor Virtual Global Healthcare Conference
02. September 2020 16:02 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...
Fluidigm Granted FDA Emergency Use Authorization for Saliva-Based Advanta Dx SARS-CoV-2 RT-PCR Assay for COVID-19
25. August 2020 23:00 ET
|
Fluidigm Corporation
Easy-to-Administer Saliva Test for COVID-19 Available for Immediate Shipment Extraction-Free, Real-Time PCR Workflow with Capacity of up to 6,000 Tests per Day per System Demonstrated 100 Percent...
Fluidigm Announces Conference Call and Webcast of Second Quarter 2020 Financial Results
06. Juli 2020 16:02 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., July 06, 2020 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive...